gait with cueing wearable device a… for Parkinson's (NCT06733077)
Reduce gait freezing with cueing
- Trial ID
- NCT06733077
- Official Title
- Development of Digital Diagnostics and Intervention Services for Parkinson's Disease
- Goal
- Reduce gait freezing with cueing
- Phase
- NA
- Status
- RECRUITING
- Sponsor
- University of Exeter
- Study Type
- INTERVENTIONAL
- Enrollment
- 80 participants
- Conditions
- Healthy Controls, Parkinson's Disease
- Interventions
- gait with cueing wearable device and neuro-ocular performance
Summary For Families
The goal is to improve digital diagnosis and support for walking problems in Parkinson's, especially daily freezing of gait and the fast, shuffling steps called festination. The approach combines a wearable cueing device that delivers timed sensory prompts to the legs to help regularize stepping, with neuro-ocular tests that measure eye and visual-motor performance to detect instability and help tailor the intervention. Adults with Parkinson's who report daily freezing or festination, can walk for at least 5 minutes (with or without an aid), have MoCA scores above 21, and normal or corrected vision are eligible. Healthy adults can join as controls if they can walk at least 3 minutes and meet the same vision and cognition requirements, while people with implants like deep brain stimulators or pacemakers or skin issues on the calves are excluded.
Locations
- University of Exeter, Exeter, United Kingdom
Frequently Asked Questions
- What is this trial testing?
- This trial is studying gait with cueing wearable device and neuro-ocular performance. The goal is to improve digital diagnosis and support for walking problems in Parkinson's, especially daily freezing of gait and the fast, shuffling steps called festination. The approach combines a wearable cueing device that delivers timed sensory prompts to the legs to help regularize stepping, with neuro-ocular tests that measure eye and visual-motor performance to detect instability and help tailor the intervention. Adults with Parkinson's who report daily freezing or festination, can walk for at least 5 minutes (with or without an aid), have MoCA scores above 21, and normal or corrected vision are eligible. Healthy adults can join as controls if they can walk at least 3 minutes and meet the same vision and cognition requirements, while people with implants like deep brain stimulators or pacemakers or skin issues on the calves are excluded.
- Who can participate?
- Participants must be at least 18 Years.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- You are never charged a fee to join a legitimate clinical trial, and the study treatment and study-specific tests are provided by the trial sponsor at no charge. In the US, routine care you would receive anyway can still be billed to you or your insurance; coverage rules differ by country, and trials in the UK and Canada usually run through public health systems. Travel, parking, and time are real costs, and some trials reimburse them while others do not. Before enrolling, ask the study coordinator to explain in writing what is and is not covered.
- How long does the trial last?
- This trial is estimated to last approximately 1 year and 3 months.
- Can I leave the trial if I change my mind?
- Yes. You can withdraw from any clinical trial at any time, for any reason, without affecting your standard medical care. Trials are voluntary by law. The team may ask if you are willing to do a brief exit visit so they can collect safety information, but you are not obligated.
- Can my spouse or care partner come with me to visits?
- In most cases yes, and it is often encouraged. Care partners can help with notes, questions, and getting home safely after a long visit. Some study assessments do need to happen one on one, but care partners are usually welcome for the rest of the appointment.
- Will I get a placebo in this trial?
- Everyone in this trial receives the experimental treatment. There is no placebo group.
- What procedures are involved in this trial?
- Based on the protocol, this trial involves: Wearable / at-home monitoring (non-invasive). Confirm the full schedule with the study coordinator.